Concepedia

Sandrine Bonnet-Lignon

SB

Statistics

Publications

2

Citations

72

H-Index

2

Active since

2014

Affiliations

Sanofi (France)(Current)

Sandrine Bonnet-Lignon is an author at Sanofi (France) specializing in medicinal chemistry, pharmacology, and ligand binding.

Publications per year

2014–2014

2

Publications

2

<i>N</i>-[6-(4-Butanoyl-5-methyl-1<i>H</i>-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1<i>H</i>-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist

Christophe Boldron, Angélina Besse, Marie-Françoise Bordes et al. · Journal of Medicinal Chemistry · 2014 · 49 citations · Full text

, , +14

SAR216471, an alternative to the use of currently available P2Y12 receptor inhibitors?

Nathalie Delesque-Touchard, A. M. Pflieger, Sandrine Bonnet-Lignon et al. · Thrombosis Research · 2014 · 23 citations

, , +7

1–2 of 2